The paracrine induction of prostate cancer progression by caveolin-1

Chun Jung Lin, Eun Jin Yun, U. Ging Lo, Yu Ling Tai, Su Deng, Elizabeth Hernandez, Andrew Dang, Yu An Chen, Debabrata Saha, Ping Mu, Ho Lin, Tsai Kun Li, Tang Long Shen, Chih Ho Lai, Jer Tsong Hsieh

Research output: Contribution to journalArticle

Abstract

A subpopulation of cancer stem cells (CSCs) plays a critical role of cancer progression, recurrence, and therapeutic resistance. Many studies have indicated that castration-resistant prostate cancer (CRPC) is associated with stem cell phenotypes, which could further promote neuroendocrine transdifferentiation. Although only a small subset of genetically pre-programmed cells in each organ has stem cell capability, CSCs appear to be inducible among a heterogeneous cancer cell population. However, the inductive mechanism(s) leading to the emergence of these CSCs are not fully understood in CRPC. Tumor cells actively produce, release, and utilize exosomes to promote cancer development and metastasis, cancer immune evasion as well as chemotherapeutic resistance; the impact of tumor-derived exosomes (TDE) and its cargo on prostate cancer (PCa) development is still unclear. In this study, we demonstrate that the presence of Cav-1 in TDE acts as a potent driver to induce CSC phenotypes and epithelial–mesenchymal transition in PCa undergoing neuroendocrine differentiation through NFκB signaling pathway. Furthermore, Cav-1 in mCRPC-derived exosomes is capable of inducing radio- and chemo-resistance in recipient cells. Collectively, these data support Cav-1 as a critical driver for mCRPC progression.

Original languageEnglish (US)
Article number834
JournalCell Death and Disease
Volume10
Issue number11
DOIs
StatePublished - Nov 1 2019

Fingerprint

Caveolin 1
Prostatic Neoplasms
Exosomes
Neoplastic Stem Cells
Neoplasms
Castration
Stem Cells
Phenotype
Immune Evasion
Radio
Neoplasm Metastasis
Recurrence
Population

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

The paracrine induction of prostate cancer progression by caveolin-1. / Lin, Chun Jung; Yun, Eun Jin; Lo, U. Ging; Tai, Yu Ling; Deng, Su; Hernandez, Elizabeth; Dang, Andrew; Chen, Yu An; Saha, Debabrata; Mu, Ping; Lin, Ho; Li, Tsai Kun; Shen, Tang Long; Lai, Chih Ho; Hsieh, Jer Tsong.

In: Cell Death and Disease, Vol. 10, No. 11, 834, 01.11.2019.

Research output: Contribution to journalArticle

Lin, CJ, Yun, EJ, Lo, UG, Tai, YL, Deng, S, Hernandez, E, Dang, A, Chen, YA, Saha, D, Mu, P, Lin, H, Li, TK, Shen, TL, Lai, CH & Hsieh, JT 2019, 'The paracrine induction of prostate cancer progression by caveolin-1', Cell Death and Disease, vol. 10, no. 11, 834. https://doi.org/10.1038/s41419-019-2066-3
Lin, Chun Jung ; Yun, Eun Jin ; Lo, U. Ging ; Tai, Yu Ling ; Deng, Su ; Hernandez, Elizabeth ; Dang, Andrew ; Chen, Yu An ; Saha, Debabrata ; Mu, Ping ; Lin, Ho ; Li, Tsai Kun ; Shen, Tang Long ; Lai, Chih Ho ; Hsieh, Jer Tsong. / The paracrine induction of prostate cancer progression by caveolin-1. In: Cell Death and Disease. 2019 ; Vol. 10, No. 11.
@article{ca28786aad8a4a9290dfb0859a27eb76,
title = "The paracrine induction of prostate cancer progression by caveolin-1",
abstract = "A subpopulation of cancer stem cells (CSCs) plays a critical role of cancer progression, recurrence, and therapeutic resistance. Many studies have indicated that castration-resistant prostate cancer (CRPC) is associated with stem cell phenotypes, which could further promote neuroendocrine transdifferentiation. Although only a small subset of genetically pre-programmed cells in each organ has stem cell capability, CSCs appear to be inducible among a heterogeneous cancer cell population. However, the inductive mechanism(s) leading to the emergence of these CSCs are not fully understood in CRPC. Tumor cells actively produce, release, and utilize exosomes to promote cancer development and metastasis, cancer immune evasion as well as chemotherapeutic resistance; the impact of tumor-derived exosomes (TDE) and its cargo on prostate cancer (PCa) development is still unclear. In this study, we demonstrate that the presence of Cav-1 in TDE acts as a potent driver to induce CSC phenotypes and epithelial–mesenchymal transition in PCa undergoing neuroendocrine differentiation through NFκB signaling pathway. Furthermore, Cav-1 in mCRPC-derived exosomes is capable of inducing radio- and chemo-resistance in recipient cells. Collectively, these data support Cav-1 as a critical driver for mCRPC progression.",
author = "Lin, {Chun Jung} and Yun, {Eun Jin} and Lo, {U. Ging} and Tai, {Yu Ling} and Su Deng and Elizabeth Hernandez and Andrew Dang and Chen, {Yu An} and Debabrata Saha and Ping Mu and Ho Lin and Li, {Tsai Kun} and Shen, {Tang Long} and Lai, {Chih Ho} and Hsieh, {Jer Tsong}",
year = "2019",
month = "11",
day = "1",
doi = "10.1038/s41419-019-2066-3",
language = "English (US)",
volume = "10",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - The paracrine induction of prostate cancer progression by caveolin-1

AU - Lin, Chun Jung

AU - Yun, Eun Jin

AU - Lo, U. Ging

AU - Tai, Yu Ling

AU - Deng, Su

AU - Hernandez, Elizabeth

AU - Dang, Andrew

AU - Chen, Yu An

AU - Saha, Debabrata

AU - Mu, Ping

AU - Lin, Ho

AU - Li, Tsai Kun

AU - Shen, Tang Long

AU - Lai, Chih Ho

AU - Hsieh, Jer Tsong

PY - 2019/11/1

Y1 - 2019/11/1

N2 - A subpopulation of cancer stem cells (CSCs) plays a critical role of cancer progression, recurrence, and therapeutic resistance. Many studies have indicated that castration-resistant prostate cancer (CRPC) is associated with stem cell phenotypes, which could further promote neuroendocrine transdifferentiation. Although only a small subset of genetically pre-programmed cells in each organ has stem cell capability, CSCs appear to be inducible among a heterogeneous cancer cell population. However, the inductive mechanism(s) leading to the emergence of these CSCs are not fully understood in CRPC. Tumor cells actively produce, release, and utilize exosomes to promote cancer development and metastasis, cancer immune evasion as well as chemotherapeutic resistance; the impact of tumor-derived exosomes (TDE) and its cargo on prostate cancer (PCa) development is still unclear. In this study, we demonstrate that the presence of Cav-1 in TDE acts as a potent driver to induce CSC phenotypes and epithelial–mesenchymal transition in PCa undergoing neuroendocrine differentiation through NFκB signaling pathway. Furthermore, Cav-1 in mCRPC-derived exosomes is capable of inducing radio- and chemo-resistance in recipient cells. Collectively, these data support Cav-1 as a critical driver for mCRPC progression.

AB - A subpopulation of cancer stem cells (CSCs) plays a critical role of cancer progression, recurrence, and therapeutic resistance. Many studies have indicated that castration-resistant prostate cancer (CRPC) is associated with stem cell phenotypes, which could further promote neuroendocrine transdifferentiation. Although only a small subset of genetically pre-programmed cells in each organ has stem cell capability, CSCs appear to be inducible among a heterogeneous cancer cell population. However, the inductive mechanism(s) leading to the emergence of these CSCs are not fully understood in CRPC. Tumor cells actively produce, release, and utilize exosomes to promote cancer development and metastasis, cancer immune evasion as well as chemotherapeutic resistance; the impact of tumor-derived exosomes (TDE) and its cargo on prostate cancer (PCa) development is still unclear. In this study, we demonstrate that the presence of Cav-1 in TDE acts as a potent driver to induce CSC phenotypes and epithelial–mesenchymal transition in PCa undergoing neuroendocrine differentiation through NFκB signaling pathway. Furthermore, Cav-1 in mCRPC-derived exosomes is capable of inducing radio- and chemo-resistance in recipient cells. Collectively, these data support Cav-1 as a critical driver for mCRPC progression.

UR - http://www.scopus.com/inward/record.url?scp=85074370548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074370548&partnerID=8YFLogxK

U2 - 10.1038/s41419-019-2066-3

DO - 10.1038/s41419-019-2066-3

M3 - Article

C2 - 31685812

AN - SCOPUS:85074370548

VL - 10

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 11

M1 - 834

ER -